Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors

Abstract Artificial bone graft substitutes, such as Calcibon, are becoming increasingly interesting as they do not cause donor site morbidity which is an advantage compared to autologous bone grafts. The aim of this study was to evaluate the efficacy and potential complications associated with the u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joerg Friesenbichler, Werner Maurer-Ertl, Marko Bergovec, Lukas A. Holzer, Kathrin Ogris, Lukas Leitner, Andreas Leithner
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dced57d5ce424c1daf88dda5487ac74d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!